Eight BC health researchers have been funded in MSFHR’s second Innovation to Commercialization (I2C) competition. Each will receive funding to advance their medical treatments, diagnostic tools and assistive technologies towards practical application to improve health outcomes and enrich the health innovation ecosystem in BC.
Now in its second year, the I2C Program is designed to help BC health researchers advance their discoveries or inventions towards use in patient populations to improve health outcomes, benefit society, and enrich the health innovation ecosystem in BC. These researchers and their research programs help grow BC’s talent pool and contribute to a strong, sustainable knowledge economy.
The eight 2018 I2C award recipients, working at six BC institutions, are advancing health innovations that range from new ways to detect prostate cancer, to a novel treatment for inflammatory bowel disease and a wearable exoskeleton to increase the mobility of people with lower limb disabilities.